A modular NIRS system for clinical measurement of impaired skeletal muscle oxygenation. J. Appl. Physiol. 88: 315-325, 2000.-Near-infrared spectrometry (NIRS) is a well-known method used to measure in vivo tissue oxygenation and hemodynamics. This method is used to derive relative measures of hemoglobin (Hb) ϩ myoglobin (Mb) oxygenation and total Hb (tHb) accumulation from measurements of optical attenuation at discrete wavelengths. We present the design and validation of a new NIRS oxygenation analyzer for the measurement of muscle oxygenation kinetics. This design optimizes optical sensitivity and detector wavelength flexibility while minimizing component and construction costs. Using in vitro validations, we demonstrate 1) general optical linearity, 2) system stability, and 3) measurement accuracy for isolated Hb. Using in vivo validations, we demonstrate 1) expected oxygenation changes during ischemia and reactive hyperemia, 2) expected oxygenation changes during muscle exercise, 3) a close correlation between changes in oxyhemoglobin and oxymyoglobin and changes in deoxyhemoglobin and deoxymyoglobin and limb volume by venous occlusion plethysmography, and 4) a minimal contribution from movement artifact on the detected signals. We also demonstrate the ability of this system to detect abnormal patterns of tissue oxygenation in a wellcharacterized patient with a deficiency of skeletal muscle coenzyme Q 10 . We conclude that this is a valid system design for the precise, accurate, and sensitive detection of changes in bulk skeletal muscle oxygenation, can be constructed economically, and can be used diagnostically in patients with disorders of skeletal muscle energy metabolism. near-infrared spectrometry; hemoglobin; myoglobin; exercise; movement artifacts; metabolic disease; coenzyme Q 10 deficiency
near-infrared spectrometry; hemoglobin; myoglobin; exercise; movement artifacts; metabolic disease; coenzyme Q 10 deficiency NEAR-INFRARED SPECTROMETRY (NIRS) is a well-established technique for monitoring hemoglobin (Hb) and myoglobin (Mb) oxygenation in vivo and noninvasively at the site of tissue (8, 9, 12) . Briefly, with this method, optical absorption is measured across tissue (such as the forearm or head) at multiple wavelengths. Relative estimates of changes in oxygenation are calculated from the wavelength-specific absorption and the specific extinction coefficients of Hb and Mb (also known in the literature as the NIRS ''algorithm'') (29) . As valuable as these sorts of measurements may be, there are very few available, much less affordable, NIRS devices (Table 1) . Although a few can be purchased commercially (7, 9, 17, 26) , others are available only if constructed on the basis of their descriptions in the literature (10, 11) . In general, commercially available instruments are very simple in construction (e.g., RunMan, NIM), at the possible expense of signal-to-noise ratio and optical sensitivity, or are very complex in construction [e.g., NIRO 500 (Hamamatsu, Bridgewater, NJ) or Oximeter (ISS)] and expensive ( Table 1) .
None of the available instruments, either those described in the literature or those that are commercially available, are designed in a modular fashion or to allow for changes to be made in wavelengths at which measurements are made. Therefore, we present the design of a new NIRS system that addresses all these design limitations. Although the described NIRS system is based on methodology previously reported (7, 9, 24, 29) , the principal advantages of the design presented here are that 1) it is based on a broadband light source in combination with continuous light measurement (i.e., without light intensity modulation), 2) it is modular (i.e., it provides the flexibility to vary the wavelengths at which measurements are made), 3) it is simple, 4) it is easy to build, and 5) because it relies on readily available and relatively inexpensive optoelectronic components, any analog-to-digital converter, and any desktop personal computer, it is inexpensive to build.
Using a combination of in vitro and in vivo measurements, we demonstrate that 1) this design produces a stable and optically linear instrument, 2) it can detect
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biological absorbances in vitro that are accurate, 3) it can be used on the skeletal muscle of healthy human subjects to produce data that are consistent with NIRS measurements produced by other NIRS devices and with parallel measurements that use other methodologies, 4) it can detect the expected evidences of abnormal patterns of tissue oxygenation and deoxygenation in a human patient with an inborn error of skeletal muscle metabolism that should preclude normal skeletal muscle O 2 extraction, and 5) the data collected from this patient are of sufficient quality that they may be used as a component of sophisticated clinical neuromuscular diagnosis.
METHODS

System Design
A modular design paradigm was used for construction of the NIRS system ( Fig. 1) , thereby allowing the flexibility to change the light source intensity, the light source spectral characteristics, the number of wavelengths to be sampled, and the detector wavelengths or sensitivity. A 100-W, quartz tungsten halogen lamp (model 6333, Oriel, Stratford, CT) driven by a constant-current power supply (model 68830, Oriel) was used as the light source. The output of the lamp was filtered using a colored glass filter (model 59545, Oriel) to remove ultraviolet and visible light and then coupled to a fiber-optic bundle (model 77533, Oriel), hereafter called the source fiber bundle, by a fiber bundle-focusing assembly (model 77799, Oriel). Light emerging from tissue was collected using a fiber-optic bundle (detector fiber bundle; Fiberguide Industries, Stirling, NJ) placed directly over the muscle of interest (flexor digitorum profundus) (3), ϳ5 cm lateral from the source fiber-optic bundle. The detector fibers were divided into four legs, and light output from each individual leg was band-pass filtered using readily commercially available narrow-band interference filters at wavelengths of 770, 820, 870, and 905 nm (models S10-770-A, S10-820-A, S10-870-A, and S10-905-A, respectively, Corion, Holliston, MA). The 905-nm channel was not used in the present validation. The wavelengths were chosen to cover the near-infrared range of interest over an even spacing (7) and to maximize the sensitivity of absorption changes in response to tissue oxygenation (7, 29) . Light outputs of the interference filters were measured in parallel by use of separate gallium-arsenide photocathode photomultiplier tubes (PMTs; model R928, Hamamatsu). PMTs were chosen as optical detectors because of their intrinsically high optical sensitivity. Each PMT was enclosed in light-tight aluminum housing with the inner surfaces coated in black paint, and fiber-to-PMT adapters were constructed as stepped cylinders and fitted onto the enclosures. High-voltage socket power supplies (HC123-01, Hamamatsu) were incorporated inside PMT housings and driven from a Ϯ15 V regulated power supply. The output currents of each of the PMTs were signal conditioned in parallel; briefly, a current-to-voltage converter converted the PMT output current to a voltage that was amplified and low-pass filtered. The output voltage of each channel was sampled using a data acquisition system (NI-DAQ-16L, LabView version 3.1, National Instruments, Austin, TX) interfaced to a computer (Macintosh Quadra 700, Apple Computer, Cupertino, CA). All voltage signals were sampled at 10 Hz and filtered using a five-point decimation-smoothing filter. Changes in optical absorption (⌬A) of tissue were calculated at each wavelength from the logarithmic ratio of measured output voltage (V o ) as follows
The dark voltage (V dark ) was the output voltage with no source illumination, and the baseline voltage (V b ) was the output voltage measured from the forearm at rest, before circulatory occlusion or exercise. V dark and V b were calculated from 30-s averages of the voltage at each wavelength. Therefore, absorption changes were calculated as a function of time, ⌬A(t), with reference to the baseline absorption of tissue (i.e., at rest). As in other optical systems, the accuracy of ⌬A is a function of the linearity of the optical detector subsystem and the implicit assumption that lumped system losses remain constant through the duration of the measurement. This is validated in Optical and Electrical Performance Validation.
The measured changes in optical absorption were converted to changes (⌬) in concentrations of oxygenated (Hb ϩ Mb) and deoxygenated (Hb ϩ Mb) [⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) ] and oxidized cytochrome aa 3 (⌬ox-cyt) on the basis of the method of Wray et al. (29) . Briefly, by making the assumption that the change in absorption at each wavelength is the linear combination of the three changing concentrations (i), Eq. 2 results, where ⑀ ,i is the molar extinction coefficient of chromophore i at wavelength , ⌬C i is the change in concentration of chromophore i, and d is the optical pathlength. Thus the measured absorptions were multiplied by a matrix of NIRS coefficients obtained by substituting the intrinsic molar extinction coefficients of ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) (29) and oxidized minus reduced absorption coefficients of cytochrome aa 3 (7) into Eq. 2 and inverting the matrix (Eq. 3). This provides three equations for the three unknowns 
Thus, on the basis of the intrinsic optical-physical characteristics described in Eq. 2, Eq. 3 displays the matrix operators (including inversion of the extinction coefficients used) to make the calculations we present. Although we chose previously published extinction coefficients, the validity of our choices of extinction coefficients (in the context of our instrument design and application to the collection of optical signals from the human forearm) required in vitro as well as in vivo validation.
Optical and Electrical Performance Validation
The absorption linearity measurement was determined by cascading two filter wheels containing neutral density filters of known absorption and placing them between the source and detector fiber bundles. Percent linearity over the range of 3-5 optical density units (OD; this absorption range was chosen by comparing the voltage outputs from the human forearm with neutral density filters) was 3% and was within manufacturer specification of accuracy for the filters. Because such an in vitro method is not sensitive to small deviations from linearity, two additional approaches were used: 1) in vitro measurements of Hb solutions of known oxygenation and 2) comparison of the ⌬tHb signal with blood volume measured in vivo by strain-gauge plethysmography.
System outputs were also evaluated for drift and random noise. Absorptions at the three wavelengths were measured at 4 OD for 1 h, and a 5-min moving-average filter was imposed to significantly attenuate random noise during the measurement of drift. System drift was defined as the maximum deviation of the absorption from its starting reference value in 1 h. Random noise was estimated as the standard deviation of absorption over a duration equal to 5 min at 4 OD.
System Validation
In vitro. To validate the ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) signal outputs of the NIRS system in vitro, an oxygenated Hb solution was prepared (29) from human erythrocytes, and its concentration was measured using the CO-oximeter add-on unit (model IL482, Instrumentation Laboratories, Norwood, MA) of a standard laboratory blood gas analyzer. The Hb solution was diluted to the physiological concentration range of 30-420 mM and placed in a custom 1-in. vial between the source and detector fibers of the NIRS system, and sodium dithionite was added to completely reduce HbO 2 (30) . NIRS measurements were then compared with tHb measured using the CO-oximeter.
In vivo: measurement of skeletal muscle O 2 availability. In vivo validations of the system were performed in humans on skeletal muscle during rest, ischemia, hyperemia, and exercise. After the subjects gave informed consent to the protocol (approved by the Institutional Review Boards of Presbyterian Hospital and the University of Texas Southwestern Medical Center), we performed a series of in vivo validation studies on a total of 12 healthy human subjects. To assess the ability of this device to detect disorders of skeletal muscle oxidative metabolism, we compared these results with those collected from a well-characterized (23) patient with coenzyme Q 10 deficiency, a deficiency in one of the enzymes of the electron transport chain. In the conduct of these in vivo validations, five of the healthy subjects participated during ischemia and exercise and five during venous occlusion; three healthy subjects were controls for the coenzyme Q 10 -deficient patient.
The coenzyme Q 10 -deficient patient was chosen for study, because the underlying biochemical defect and the pathophysiology of large muscle exercise have been well characterized (23) . Because this enzyme deficiency severely limits muscle oxidative phosphorylation, systemic arteriovenous difference is virtually unchanged from rest during peak exercise, consistent with severely impaired O 2 extraction by working muscle. Thus we would expect that the tissue deoxygenation normally seen in healthy subjects during exercise would not occur in this patient.
Statistics ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) are usually expressed in units of millimolar times centimeters as changes from baseline values (defined as 0) during rest. Differences between calculated means (of the form x i vs. x j ) were determined by two-tailed group t-test (19) . Statistical significance was defined for P Ͻ 0.05. Rates of decline during ischemia were calculated from a linear regression into the 1st min of the ⌬oxy (Hb ϩ Mb) decay after circulatory occlusion. The time to ischemic steady state for ⌬oxy (Hb ϩ Mb) was defined as the time elapsed from circulatory occlusion to time beyond which continuing circulatory occlusion produced no change in the magnitude of the signal.
RESULTS
Optical Performance
Signal stability and random noise. The measured output drift was 0.004, 0.001, and 0.004 OD/h at wavelengths of 770, 820, and 870 nm, respectively. Random noise standard deviations were measured as 0.005, 0.005, and 0.008 OD at wavelengths of 770, 820, and 870 nm, respectively.
Absorbance linearity. The absorption measured across neutral density filters (⌬A meas ) with the customdesigned NIRS device was compared with the manufacturer-specified absorption (⌬A f ) for each filter at the wavelengths of 770, 820, and 870 nm. The leastsquares estimates of the slope and intercept of the linear fit at 770 nm [0.97 Ϯ 0.02 and 0.01 Ϯ 0.02 (SE), respectively] were not different (P Ͼ 0.05) from unity or zero, respectively. Similar results were obtained from the least-squares linear fits to absorptions measured at the other discrete wavelengths. Linearity was 97% when calculated by dividing the maximum difference between the absorption and the least-squares fit by the absorption range of 1.8 OD (20) .
In Vitro Validations
Accuracy of Hb oxygenation measurements. The reduction of Hb by use of sodium dithionite produced a decrease in the ⌬oxy (Hb) signal and an increase in the ⌬deoxy (Hb) signal. Because of equal and opposite changes in the ⌬oxy (Hb) and ⌬deoxy (Hb) signals, variations in ⌬tHb were limited to signal fluctuations observed as a result of initial sample stirring. To quantitatively validate the linearity (and accuracy) of the measurement in vitro, ⌬oxy (Hb) and ⌬deoxy (Hb) were compared with the concentration of (HbO 2 ϩ Hb) measured using a standard clinical blood laboratory CO-oximeter. A linear response was observed (Fig. 2) between the NIRS and CO-oximeter measurements, with maximum deviation of the ⌬oxy (Hb) and ⌬deoxy (Hb) signals from the line of identity being 5 and 2% (of the range), respectively.
In Vivo Validations in Normal Healthy Human Skeletal Muscle
Muscle ischemia. Data were collected during 5 min of rest. Circulatory occlusion was then imposed, and the outputs of the NIRS algorithm indicated that, immedi- Fig. 2 . Validation of measurements of changes in oxy-and deoxyhemoglobin [⌬oxy (Hb) and ⌬deoxy (Hb) ] in Hb isolated from human blood by near-infrared spectrometry (NIRS) with measurements made on same Hb by a CO-oximeter. Maximum deviation from line of identity was 5 and 2% for ⌬oxy (Hb) and ⌬deoxy (Hb) , respectively. tHb, total Hb. ately after arterial occlusion, the ⌬oxy (Hb ϩ Mb) signal decreased below its rest control value (Fig. 3) , concurrent with a proportional increase in the ⌬deoxy (Hb ϩ Mb) signal, and therefore produced no net change (P Ͼ 0.05) in the ⌬tHb volume signal.
Muscle hyperemia. After the muscle oxygenation reached a stable nadir, the occluding cuff was deflated. At this point (Fig. 3) (Fig. 4) and then a stable and repeatable cycling of the signal (at a frequency of ϳ0.1 Hz), which was the same period as that of the RHG. The 0.1-Hz transient decreases of the ⌬oxy (Hb ϩ Mb) signal were coincident with the corresponding transient increases in the ⌬deoxy (Hb ϩ Mb) signal and the transient increase in force during each contraction.
Movement artifacts. Optical measurements can be very sensitive to movement artifacts. During RHG exercise in normal nonischemic muscle (Fig. 5) , the ⌬oxy (Hb ϩ Mb) signal contained two components: 1) a decrease in the average or filtered ⌬oxy (Hb ϩ Mb) signal over the entire exercise period (Fig. 5C ) and 2) cyclical changes during each contraction-relaxation cycle (Fig.  5B) . To estimate the contribution of movement artifacts to the above signal, RHG was repeated under two different conditions where tissue oxygenation could be expected to remain constant: 1) normal ''loaded'' exercise performed after 10 min of ischemia (Fig. 5, D and E) and 2) ''no-load'' exercise, i.e., exercise (with normal finger flexion activity) performed without resistance to movement (Fig. 6) .
With 10 min of ischemia before RHG exercise, the average ⌬oxy (Hb ϩ Mb) signal reached a steady-state nadir (normalized to Ϫ1.0 in Fig. 5, D and E) . Therefore, because exercise in such a condition of an ischemic nadir could not cause a further reduction in the tissue oxygenation, any cyclical signal changes detected during RHG exercise in this condition could only arise from movement artifacts. This amplitude of cyclical ⌬oxy (Hb ϩ Mb) signal changes during ischemic exercise (Fig. 5) , expressed as a percentage of the filtered ⌬oxy (Hb ϩ Mb) change during RHG exercise, performed at the same intensity but without circulatory occlusion, was 16%. Similarly, the amplitude of cyclical ⌬oxy (HbϩMb) signal changes during ischemic exercise, as a percentage of the cyclical ⌬oxy (Hb ϩ Mb) changes during RHG exercise, was 34%.
Similarly, during unloaded finger flexion exercise (Fig. 6) , there was no distinct change in the average ⌬oxy (Hb ϩ Mb) signal. Thus this procedure could be used to estimate the contribution to the overall signal from movement with tissue ''normally'' oxygenated. Additionally, there was no distinctly different cyclical ⌬oxy (HbϩMb) signal during no-load exercise.
Validation of tHb with venous occlusion plethysmography. During venous occlusion, the initial rate of increase of total limb cross-sectional volume (⌬tV I ) during the first 20 s, measured using strain-gauge plethysmography, was 4.3 Ϯ 0.7 ml · 100 ml tissue Ϫ1 · min Ϫ1 . The ⌬tV I was the same for all venous occlusion pressures (20-70 mmHg; Fig. 7) . Each of the signals was normalized, at their respective occlusion pressures, to the total signal change. Expressed in this manner, the ⌬tV I was 2.3 Ϯ 0.3%/s. The changes in total Hb volume (⌬tHb volume ) were linearly correlated with the change in total volume (⌬tV; r 2 ϭ 0.99; Fig. 8) . Likewise, the initial rate of increase of tHb volume (⌬tHb I ), normalized to the maximum signal change at each occlusion pressure, was 2.3 Ϯ 0.5%/s and was not different from ⌬tV I . With cuff deflation after venous occlusion, ⌬tV and ⌬tHb volume decreased in a characteristic biphasic manner, with a rapid decline lasting ϳ5 s followed by a slower decline to rest values over ϳ1 min (Fig. 7) .
In Vivo Validations in Skeletal Muscle of the Coenzyme Q 10 -Deficient Patient
Muscle ischemia. Circulatory arrest produced an immediate decline in the ⌬oxy (Hb ϩ Mb) signal. The initial rate of decline of ⌬oxy (Hb ϩ Mb) in the patient (Ϫ0.0076 mM·cm·s Ϫ1 or 56%/min) was not different from that in healthy subjects. It took about the same time (218 s) to reach an ischemic nadir, and the level of the ischemic steady-state nadir was about the same as in healthy subjects. Again, as in healthy subjects, circulatory occlusion resulted in an increase in the ⌬deoxy (Hb ϩ Mb) signal that was approximately stoichiometric, so that there was no net change in ⌬tHb.
Muscle exercise. In contrast to healthy subjects, RHG exercise caused an increase in ⌬oxy (Hb ϩ Mb) above rest level (Fig. 9) . During the first 110 s after the onset of RHG exercise, the average ⌬oxy (Hb ϩ Mb) signal reached a peak value of 24.5% above rest level [with use of the arbitrary range where 0 ϵ ⌬oxy (Hb ϩ Mb) at rest and 100 ϵ ⌬oxy (Hb ϩ Mb) at the ischemic nadir]. This increase in the average ⌬oxy (Hb ϩ Mb) signal was accompanied by a decrease in the ⌬deoxy (Hb ϩ Mb) signal and was very different from that in healthy subjects. Because the increase in the ⌬oxy (Hb ϩ Mb) signal was greater than in the ⌬deoxy (Hb ϩ Mb) signal, a small net increase in ⌬tHb volume was detected in the coenzyme Q 10 -deficient patient during RHG exercise.
DISCUSSION
The inherent difficulties in making NIRS measurements of internal physiological systems often have caused the focus of much of this work to be technological. Most of the engineering approaches to making these measurements are focused on designing as thorough a measurement system as possible (5, 9, 13) , at the cost of instrument expense and inflexibility, or on designing a simple and inexpensive system that can be used to examine exercising skeletal muscle, possibly at the additional cost of sensitivity (15, 16, 18) . We describe an intermediate approach that is relatively inexpensive to construct and relatively simple to implement and produces adequate and stable signal-to-noise ratio. It is clear that our implementation of NIRS methodology can successfully monitor skeletal muscle metabolism in exercising human skeletal muscle, that the results can be validated in vitro and in vivo, and that the results can be extended to diagnose clinical conditions. Thus we believe that our implementation of NIRS technology will provide a much more widespread Fig. 7 . Validation of changes (mean of 5 healthy subjects) in ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) measured in human forearm by NIRS by comparing their summed signal (⌬tHb volume ) with changes in total limb volume (⌬tV) measured simultaneously using venous occlusion plethysmography. Limb volume changes were induced by subdiastolic congestion with an occlusion cuff inflated to pressures (P) of 20, 50, and 70 mmHg. In each case, initial rate of increase of total limb cross-sectional volume (⌬tV I ) during first 20 s was not different from initial rate of increase of ⌬tHb (⌬tHb I ) normalized to maximum signal change. With cuff deflation after venous occlusion, ⌬tV and ⌬tHb decreased in a characteristic biphasic manner, with a rapid decline lasting ϳ5 s, then a slower decline to rest values over ϳ1 min. availability to study skeletal muscle oxidative metabolism.
Optical and Electrical Performance Validation
Signal stability. Our estimate of signal stability is a combination of the effect of random noise (electrical and optical) and the overall stability of the system. Over a 60-min period, the sum total of the absolute value of the system drift in the three channels combined was ϳ1% of the absolute value of the sum of the absorbances in all channels during ischemia. Thus it is unlikely that signal instability contributes measurable error to our calculations of tissue oxygenation.
Error propagation analysis of the NIRS system. Beyond stability and the random noise of the absorption, a more rigorous approach to evaluating system noise is to calculate the magnitude of the error of the measurement itself. Because absorption is not the final measurement, it is more valuable to calculate the errors propagated in the process of actually calculating ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) . On the basis of our algorithm (Eq. 3), the worst-case propagated errors were calculated from the root-square sum of the random noise at each wavelength. Therefore, the net worst-case drift (D) for ⌬oxy Together, the drift (D) noise is only about one-half the random noise standard deviation (): for ⌬oxy (Hb ϩ Mb) ϳ3% (0.026 mM · cm per mM · cm) of the total signal change during ischemia and ϳ9% (0.026 mM · cm per 0.3 mM · cm) of the signal change during maximal RHG exercise.
Absorbance linearity. The linearity of the absorption measurement was defined as the maximum ⌬A meas from a least-squares line fit with neutral density filters (⌬A f ). On the basis of the slope and intercept of the straight line relating ⌬A meas with ⌬A f , the 97% linearity (over 1.8 OD) and zero intercept indicated near-perfect linearity.
In Vitro Validations
Hb cuvette and accuracy data. Because the NIRS outputs were so consistent with CO-oximeter outputs, with negligible cross talk between ⌬oxy (Hb) and ⌬deoxy (Hb) , the NIRS algorithm (Eq. 3) was considered valid in converting net O 2 -dependent absorption change to the individual absorptions of ⌬oxy (Hb) and ⌬deoxy (Hb) in vitro. The only corrections remaining would be those for the actual pathlength in vivo (structural impediments to photon migration plus changes in sourcedetector orientation during exercise) and differential changes in the concentrations of individual chromophores not part of the derivation of the algorithm coefficients. We believe that most of these are accounted for in our in vivo validations.
In Vivo Validations
Measurement of tissue oxygenation by NIRS is simple but complex. It is simple, because the biophysics of optical absorption of photons by chromophores is well understood. It is complex, because 1) the absorbances of Hb and Mb are indistinguishable (7, 22) , 2) the absorbances of Hb in separate anatomic compartments (relative sizes of ''arterial,'' ''capillary,'' or ''venous'' spaces) are detected and displayed as a summed signal, 3) there is interaction between blood flow and perfusion, 4) Hb oxygenation changes monotonically from the arterial to the capillary to the venous circulation in a complex fashion (21), 5) the saturations of Hb and Mb are different and dynamically changing as a function of the rate of O 2 utilization and delivery, and 6) the effect of exercise on the pattern of photon migration is unknown. Taken together, these complications require rigorous biological validations. All our biological validations are based on the use of well-known and inherently simple physiological phenomena and comparisons by independent measures.
Muscle ischemia. During arterial occlusion, the changes in absorption at all the monitored wavelengths were qualitatively consistent with the known absorptions of Hb in vitro (29) and data from other NIRS devices (7) . Immediately after arterial occlusion, ⌬oxy (Hb ϩ Mb) decreased with an increase in ⌬deoxy (Hb ϩ Mb) (Fig. 3) . This was reasonable, because ongoing mitochondrial respiration would be expected to gradually deplete the O 2 stores present in Hb and Mb, but the arterial occlusion would fix the amount of tHb. As expected, the sum of ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) (⌬tHb volume ) did not change during arterial occlusion.
The ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) signals reached a steady-state nadir after 6-7 min of ischemia, an additional 5 min (ischemic) of RHG exercise (at 33% of maximal voluntary contractile force), and then another 60 s of rest. We found that the ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) signals were not different from those after the initial ischemia. So, although this methodology cannot determine absolute concentration of O 2 , we do know that this was more than twice the time previously calculated to completely deplete the tissue of O 2 (4) and that exercise did not result in any further deoxygenation. Although this may be a condition where the PO 2 in most compartments is nearly equal to zero (4), it is certainly functionally indistinguishable from ''zero''; thus we believe it is most justified to call it a ''biological zero.''
Meaning of a biological zero. NIRS ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) signals are composed of some combination of the following chromophore absorbances: Hb in the arterial or prearteriolar space, Hb in the capillary (postarteriole to prevenule) space, Hb in the venous or postvenule space, and Mb in the muscle. Our definition of an ischemic nadir was that the summed oxygenation of these spaces in the field of view was constant at zero or at some nonzero value where the concentration gradient does not exceed the diffusion gradient (6). Our term biological zero cannot be an absolute measure of the real PO 2 in any subcellular space; rather, it means that no combination of blocking supply (ischemia) and increasing demand (muscle contractile activity) causes any further loss of oxygenation from the sum of detected chromophores. We believe this is the functional equivalent to a mean tissue PO 2 lower than the effective Michaelis-Menten constant in vivo of Mb for O 2 (14, 27, 28) and no higher than the functional MichaelisMenten constant of mitochondria for O 2 , which in vitro has been reported to be Ͻ1.0 Torr (25) .
Muscle hyperemia. After the muscle oxygenation reached a stable nadir, the occluding cuff was deflated. At this point, the ⌬oxy (Hb ϩ Mb) signal increased and the ⌬deoxy (Hb ϩ Mb) signal decreased rapidly. This led to an increase of ⌬tHb because of a greater increase in the ⌬oxy (Hb ϩ Mb) than in the ⌬deoxy (Hb ϩ Mb) signal, which reached its maximum value within 1 min after cuff release (Fig. 3 ) and then returned to control level within 7 min. We consider this reasonable: a transient excess of arterial blood creating a transient increase in total blood volume.
Muscle rhythmic exercise. During maximal RHG exercise, the ⌬oxy (Hb ϩ Mb) signal decreased until a steady state was reached within 30 s (3 contraction-relaxation cycles). Normalized to the signal change from rest to ischemic steady state, this decline was Ϫ32%. The steady-state or average value of ⌬oxy (Hb ϩ Mb) (calculated by a 10-s moving-average filter) remained below rest level until the end of exercise (Fig. 5C) . In addition to a decrease in the average ⌬oxy (Hb ϩ Mb) , cyclical changes were observed during each contraction-relaxation cycle. The sustained decrease of the ⌬oxy (Hb ϩ Mb) signal during RHG exercise indicated that the high O 2 consumption of muscle during exercise was accommodated by a combination of a net increase in O 2 extraction (oxidative phosphorylation) over delivery (blood flow), possibly in combination with a muscle pump-mediated decrease in total venous volume. Increases in ⌬deoxy (Hb ϩ Mb) were equal and opposite to that of the ⌬oxy (Hb ϩ Mb) signal; therefore, the sum (⌬tHb volume ) remained unchanged.
Estimation of movement artifacts. We calculated the magnitude of movement artifacts to overall oxygenation measurements during exercise in vivo 1) after 10 min of vascular occlusion, where muscle contraction causes no further tissue deoxygenation (4), and 2) during exercise with no load and, thus, little or no increase in muscle oxidative metabolism.
At the ischemic nadir, RHG exercise produced no further deoxygenation (Fig. 5, D and E) , so we could superimpose exercise to estimate the magnitude of movement artifact in and of itself. During RHG exercise performed during this ischemia, the small variations detected in ⌬oxy (Hb ϩ Mb) and ⌬deoxy (Hb ϩ Mb) must have arisen from movement artifacts. The amplitude of cyclical variations (movement artifacts; Fig. 5D ) was 16% of total average signal change during RHG exercise (Fig. 5C ) and 34% of the cyclical ⌬oxy (Hb ϩ Mb) amplitude during RHG exercise (Fig. 5B) . Thus the maximal contribution of movement artifacts to the average oxygenation change during RHG exercise could not be more than about one-third of the total cyclical ⌬oxy (Hb ϩ Mb) amplitude. Because the amplitude of movement artifacts was so much smaller than actual oxygenation changes, it is valid to use this NIRS methodology to monitor skeletal muscle deoxygenation patterns during RHG exercise.
Validation of tHb with venous occlusion plethysmography. As one estimate of the accuracy of the NIRS algorithm, we compared its calculation of total blood volume with an independent measure of blood volume: limb volume measurements made using venous occlusion plethysmography. Our assumption was that if two independent measurements agreed, then they were both measuring the same thing equally incorrectly, they were both getting the same outputs and their summed component errors were exactly equal and offsetting, or they were both correct.
The linear proportionality (Figs. 7 and 8) between ⌬tHb volume (NIRS) and ⌬tV (plethysmography) during subdiastolic venous congestion (r 2 ϭ 0.99) means that both are correct within the limits of each methodology. Because these two independent measures produced the same outputs at several different subdiastolic limb congestions, during the ascension to, the steady state at, and the recovery from each of three different occluding pressures (Fig. 7) , we are confident that the underlying assumptions (principally the inverse matrix solution and the coefficients in the matrix), taken as a unit, are reasonable. Moreover, because our implementation of NIRS in this setting should only detect changes in concentration of Hb, our results suggest that, during acute limb congestions, the changes in limb volume measured by strain-gauge plethysmography are dominated by the change in limb blood volume and that any accompanying changes in limb vs. optode geometry are negligible in the calculation of tHb by NIRS.
Skeletal muscle coenzyme Q 10 deficiency. We used our NIRS system to monitor muscle oxygenation in a well-characterized patient with a deficiency of skeletal muscle coenzyme Q 10 (1, 2, 23) . This patient had impaired oxidative metabolism in skeletal muscle from a reduction in coenzyme Q 10 concentration to Ͻ25% of normal, impairing the catalytic activities of complexes I-II and I-III. During large muscle exercise, patients with such mitochondrial myopathies typically exhibit premature fatigue and exercise intolerance. The impairment in muscle oxidative phosphorylation is so severe that there is no increase in the arteriovenous O 2 difference during exercise.
We found that muscle O 2 extraction during rest was not different from that of healthy subjects, consistent with previous whole body O 2 consumption measurements (23) . In contrast, although this patient exhibited a cyclic pattern of tissue oxygenation in synchrony with the pattern of RHG exercise, the ⌬oxy (Hb ϩ Mb) (Fig. 9 ) increased immediately at the onset of exercise. This increase in the average ⌬oxy (Hb ϩ Mb) signal indicates a net increase in perfusion over extraction, consistent with the previously documented absence of any increase in systemic arteriovenous O 2 difference and exaggerated systemic O 2 transport relative to O 2 utilization during cycle exercise (23) .
Summary
These data demonstrate clearly the value of NIRS measurement, in that it provides a completely noninvasive measure of these summed signals with extremely high time resolution. We have presented a system design that provides signal accuracy, stability, and sensitivity in combination with detection flexibility at relatively low cost and simple implementation. We have validated its outputs and demonstrated its utility in vivo in healthy control subjects as well as in a well-characterized human patient with skeletal muscle coenzyme Q 10 deficiency. We believe that use of such a system can become of widespread utility for routine clinical diagnoses as well as for the study of the interactions between O 2 delivery and utilization in human skeletal muscle.
